These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2189455)

  • 1. Degradation of extracellular matrix proteoglycans by human neutrophils.
    Stone PJ
    Am J Respir Cell Mol Biol; 1990 Jun; 2(6):491-2. PubMed ID: 2189455
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms of extracellular matrix proteoglycan degradation by human neutrophils.
    McGowan SE
    Am J Respir Cell Mol Biol; 1990 Mar; 2(3):271-9. PubMed ID: 2155632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular matrix proteoglycan degradation by human alveolar macrophages and neutrophils.
    McGowan SE; Thompson RJ
    J Appl Physiol (1985); 1989 Jan; 66(1):400-9. PubMed ID: 2917944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human lumbar intervertebral disc: evidence for changes in the biosynthesis and denaturation of the extracellular matrix with growth, maturation, ageing, and degeneration.
    Antoniou J; Steffen T; Nelson F; Winterbottom N; Hollander AP; Poole RA; Aebi M; Alini M
    J Clin Invest; 1996 Aug; 98(4):996-1003. PubMed ID: 8770872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Degradation of cartilage matrix proteoglycan by human neutrophils involves both elastase and cathepsin G.
    Janusz MJ; Doherty NS
    J Immunol; 1991 Jun; 146(11):3922-8. PubMed ID: 2033261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adhesive interactions between malignant cells and the extracellular matrix. Importance of proteoglycans and the ras oncogene.
    Kosir MA; Culp LA
    Surg Annu; 1990; 22():25-48. PubMed ID: 2408165
    [No Abstract]   [Full Text] [Related]  

  • 7. Association of proteoglycans with other extracellular matrix macromolecules in liver.
    Unnikrishnan VS; Sudhakaran PR
    Indian J Exp Biol; 1988 Oct; 26(10):784-9. PubMed ID: 3248833
    [No Abstract]   [Full Text] [Related]  

  • 8. Dominant role of the C-terminal domain in the binding of apolipoprotein(a) to the protein core of proteoglycans and other members of the vascular matrix.
    Scanu AM; Edelstein C; Klezovitch O
    Trends Cardiovasc Med; 1999 Oct; 9(7):196-200. PubMed ID: 10881751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early atherosclerosis in humans: role of diffuse intimal thickening and extracellular matrix proteoglycans.
    Nakashima Y; Wight TN; Sueishi K
    Cardiovasc Res; 2008 Jul; 79(1):14-23. PubMed ID: 18430750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatty acid-induced atherogenic changes in extracellular matrix proteoglycans.
    Rodriguéz-Lee M; Bondjers G; Camejo G
    Curr Opin Lipidol; 2007 Oct; 18(5):546-53. PubMed ID: 17885426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of proteoglycan metabolism by human fibroblasts maintained in an endogenous three-dimensional matrix.
    Qwarnström EE; Kinsella MG; MacFarlane SA; Page RC; Wight TN
    Eur J Cell Biol; 1992 Feb; 57(1):101-8. PubMed ID: 1639087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of stromal proteoglycans in tumour progression.
    Wegrowski Y; Maquart FX
    Crit Rev Oncol Hematol; 2004 Mar; 49(3):259-68. PubMed ID: 15036265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding and degradation of proteoglycans by cultured arterial smooth muscle cells. II. Binding sites of proteoglycans on the cell surface.
    Völker W; Schmidt A; Buddecke E; Themann H; Robenek H
    Eur J Cell Biol; 1985 Jan; 36(1):58-65. PubMed ID: 3979402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional structure and composition of the extracellular matrix.
    Bosman FT; Stamenkovic I
    J Pathol; 2003 Jul; 200(4):423-8. PubMed ID: 12845610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human granzyme B degrades aggrecan proteoglycan in matrix synthesized by chondrocytes.
    Froelich CJ; Zhang X; Turbov J; Hudig D; Winkler U; Hanna WL
    J Immunol; 1993 Dec; 151(12):7161-71. PubMed ID: 8258716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Extracellular matrix, adhesion molecules and cytoskeleton of the lung].
    Abe T; Satoh K; Motomiya M
    Kokyu To Junkan; 1993 Apr; 41(4):308-18. PubMed ID: 8516569
    [No Abstract]   [Full Text] [Related]  

  • 17. Novel regulatory mechanisms for the proteoglycans decorin and biglycan during muscle formation and muscular dystrophy.
    Brandan E; Cabello-Verrugio C; Vial C
    Matrix Biol; 2008 Oct; 27(8):700-8. PubMed ID: 18694824
    [No Abstract]   [Full Text] [Related]  

  • 18. Involvement of proteoglycans in tendinopathy.
    Parkinson J; Samiric T; Ilic MZ; Cook J; Handley CJ
    J Musculoskelet Neuronal Interact; 2011 Jun; 11(2):86-93. PubMed ID: 21625045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glomerular cell proteoglycans: their possible role in progressive glomerular disease.
    Davies M
    Exp Nephrol; 1995; 3(2):122-6. PubMed ID: 7773631
    [No Abstract]   [Full Text] [Related]  

  • 20. Messages in the matrix: proteoglycans go the distance.
    Gallagher J
    Dev Cell; 2007 Aug; 13(2):166-7. PubMed ID: 17681128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.